Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$66 969
2025
Q4
$66 Buy
+1
New +$65 ﹤0.01% 984
2024
Q1
Sell
-12
Closed -$1.49K 680
2023
Q4
$1.49K Hold
12
﹤0.01% 572
2023
Q3
$1.12K Hold
12
﹤0.01% 578
2023
Q2
$1.54K Buy
+12
New +$1.45K ﹤0.01% 586

Other funds holding DXCM

Nemes Rush Group's DXCM Position: Q1 2026 in Review

Nemes Rush Group sold out of DexCom (DXCM) in Q1 2026, closing a stake of 1 share — an estimated $66 sold.

Nemes Rush Group first reported a position in DXCM in Q2 2023 and held it in 4 quarters. The position peaked at $1.54K in Q2 2023. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Nemes Rush Group reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Nemes Rush Group sold 1 DexCom share in Q1 2026, an estimated $66.
  • Nemes Rush Group first reported a position in DexCom in Q2 2023 and held it in 4 quarters.
  • Nemes Rush Group's DexCom position peaked at $1.54K in Q2 2023.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.